Quality of life · People with BRONJ (mean age ~66 years; most treated with bisphosphonates for cancer (multiple myeloma, breast cancer) or osteoporosis)
1 finding from 1 review
Suicidality: mean number of suicide attempts over the preceding 2 weeks Timing of outcome assessment: 12 months · adults meeting 3 or more diagnostic criteria for borderline personality disorder
1 finding from 1 review
Violence perpetration · adults meeting 3 or more diagnostic criteria for borderline personality disorder
Brief admission to psychiatric hospital by self‐referral plus… showed no clear difference in violence perpetration: number of participants who perpetrated… compared with treatment (low certainty).
1 finding from 1 review
Hospital admissions: days of inpatient mental health care Timing of outcome assessment: 12 months · adults meeting 3 or more diagnostic criteria for borderline personality disorder
1 finding from 1 review
Quality of life · adults meeting 3 or more diagnostic criteria for borderline personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness · adults meeting 3 or more diagnostic criteria for borderline personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deatha Timing of outcome assessment: 12 months · adults meeting 3 or more diagnostic criteria for borderline personality disorder
Brief admission to psychiatric hospital by self‐referral plus… showed no clear difference in deatha Timing of outcome assessment: 12 months compared with treatment (low certainty).
1 finding from 1 review
Self‐harm Measured by: clinicians Timing of outcome assessment: end of treatment · adults meeting 3 or more diagnostic criteria for borderline personality disorder
1 finding from 1 review
Implant/prosthesis failure and complications · Patients with resorbed maxillae (incl. atrophic sinuses) needing implants
1 finding from 1 review
Short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of · adults with alopecia areata
Summary of findings table ‐ Oral small molecule inhibitors… leads to higher short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (high certainty).
1 finding from 1 review
Incidence of serious adverse events · adults with alopecia areata
Summary of findings table ‐ Oral small molecule inhibitors… showed no clear difference in incidence of serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Health‐related quality of life ‐ not reported · adults with alopecia areata
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Long‐term hair regrowth ≥ 75% (greater than 26 weeks of · adults with alopecia areata
Summary of findings table ‐ Oral small molecule inhibitors… leads to higher long‐term hair regrowth ≥ 75% (greater than 26 weeks of compared with placebo (high certainty).
1 finding from 1 review
Scar improvement (POSAS) (0–10, higher score = more severe scarring) · people with burn wounds likely to develop hypertrophic scarring
The review found no eligible studies for this question.
2 findings from 1 review
Pain (POSAS 0–10, higher score = more severe pain) · people with burn wounds likely to develop hypertrophic scarring
1 finding from 1 review
Pruritus · people with burn wounds likely to develop hypertrophic scarring
1 finding from 1 review
Quality of life · people with burn wounds likely to develop hypertrophic scarring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with burn wounds likely to develop hypertrophic scarring
1 finding from 1 review
Adherence · people with burn wounds likely to develop hypertrophic scarring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of · adults with alopecia areata
It is very uncertain whether summary of findings table ‐ Contact immunotherapy (diphencyprone or… changes short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (very low certainty).
1 finding from 1 review